246 related articles for article (PubMed ID: 15034146)
1. Silencer elements as possible inhibitors of pseudoexon splicing.
Sironi M; Menozzi G; Riva L; Cagliani R; Comi GP; Bresolin N; Giorda R; Pozzoli U
Nucleic Acids Res; 2004; 32(5):1783-91. PubMed ID: 15034146
[TBL] [Abstract][Full Text] [Related]
2. Systematic identification and analysis of exonic splicing silencers.
Wang Z; Rolish ME; Yeo G; Tung V; Mawson M; Burge CB
Cell; 2004 Dec; 119(6):831-45. PubMed ID: 15607979
[TBL] [Abstract][Full Text] [Related]
3. Predictive identification of exonic splicing enhancers in human genes.
Fairbrother WG; Yeh RF; Sharp PA; Burge CB
Science; 2002 Aug; 297(5583):1007-13. PubMed ID: 12114529
[TBL] [Abstract][Full Text] [Related]
4. Over-representation of exonic splicing enhancers in human intronless genes suggests multiple functions in mRNA processing.
Pozzoli U; Riva L; Menozzi G; Cagliani R; Comi GP; Bresolin N; Giorda R; Sironi M
Biochem Biophys Res Commun; 2004 Sep; 322(2):470-6. PubMed ID: 15325254
[TBL] [Abstract][Full Text] [Related]
5. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
[TBL] [Abstract][Full Text] [Related]
6. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
[TBL] [Abstract][Full Text] [Related]
7. Distribution of exonic splicing enhancer elements in human genes.
Wu Y; Zhang Y; Zhang J
Genomics; 2005 Sep; 86(3):329-36. PubMed ID: 16005179
[TBL] [Abstract][Full Text] [Related]
8. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
[TBL] [Abstract][Full Text] [Related]
9. Use of minigene systems to dissect alternative splicing elements.
Cooper TA
Methods; 2005 Dec; 37(4):331-40. PubMed ID: 16314262
[TBL] [Abstract][Full Text] [Related]
10. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
11. The ETFDH c.158A>G variation disrupts the balanced interplay of ESE- and ESS-binding proteins thereby causing missplicing and multiple Acyl-CoA dehydrogenation deficiency.
Olsen RK; Brøner S; Sabaratnam R; Doktor TK; Andersen HS; Bruun GH; Gahrn B; Stenbroen V; Olpin SE; Dobbie A; Gregersen N; Andresen BS
Hum Mutat; 2014 Jan; 35(1):86-95. PubMed ID: 24123825
[TBL] [Abstract][Full Text] [Related]
12. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
13. Computational searches for splicing signals.
Zhang XH; Leslie CS; Chasin LA
Methods; 2005 Dec; 37(4):292-305. PubMed ID: 16314258
[TBL] [Abstract][Full Text] [Related]
14. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
15. Multiple splicing defects in an intronic false exon.
Sun H; Chasin LA
Mol Cell Biol; 2000 Sep; 20(17):6414-25. PubMed ID: 10938119
[TBL] [Abstract][Full Text] [Related]
16. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail.
Meili D; Kralovicova J; Zagalak J; Bonafé L; Fiori L; Blau N; Thöny B; Vorechovsky I
Hum Mutat; 2009 May; 30(5):823-31. PubMed ID: 19280650
[TBL] [Abstract][Full Text] [Related]
17. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
18. Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.
Eng L; Coutinho G; Nahas S; Yeo G; Tanouye R; Babaei M; Dörk T; Burge C; Gatti RA
Hum Mutat; 2004 Jan; 23(1):67-76. PubMed ID: 14695534
[TBL] [Abstract][Full Text] [Related]
19. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
20. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
